Grifols formulates first euros in final refi deal
Potential high yield bond issuance for this week shot up above €2.4bn with a new €1bn offering from Grifols, the plasma medicine manufacturer based in Barcelona, which is closing the last leg of its debt refinancing.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: